Your session is about to expire
← Back to Search
Behavioral Intervention
Organizational Strategy for Substance Abuse Care Improvement (LOCI-SL Trial)
N/A
Recruiting
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline through study completion, an average of 9 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test a strategy to help clinics implement and sustain the use of an AI platform to improve care for substance abuse disorders.
Who is the study for?
This trial is for staff at provider or payer advocacy organizations, executives and managers at substance use disorder/mental health treatment agencies, clinic supervisors, counselors providing such treatments in Oregon and Indiana. It includes stakeholders from relevant state authorities and managed care organizations.
What is being tested?
The trial tests a strategy called LOCI-SL that aligns leadership across systems to implement the Lyssn AI platform for Motivational Interviewing (MI) and evidence-based practices in treating substance use disorders.
What are the potential side effects?
Since this trial involves implementation strategies rather than medical interventions, traditional side effects are not applicable. However, there may be indirect impacts on workflow or job satisfaction.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline through study completion, an average of 9 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline through study completion, an average of 9 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change on Implementation Climate Scale
Change on Implementation Leadership Scale
Secondary study objectives
Change on Evidence-based Practice Attitudes Scale
Change on Implementation Citizenship Behavior Scale
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: LOCIExperimental Treatment1 Intervention
Leadership and Organizational Change for Implementation strategy
Group II: ControlActive Control1 Intervention
assessment only through online survey
Find a Location
Who is running the clinical trial?
Pacific Institute for Research and EvaluationOTHER
27 Previous Clinical Trials
33,767 Total Patients Enrolled
Oregon Social Learning CenterOTHER
35 Previous Clinical Trials
10,410 Total Patients Enrolled
Indiana UniversityOTHER
1,044 Previous Clinical Trials
1,316,505 Total Patients Enrolled
University of California, San DiegoLead Sponsor
1,189 Previous Clinical Trials
1,587,377 Total Patients Enrolled
University of Central FloridaOTHER
93 Previous Clinical Trials
1,119,862 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control
- Group 2: LOCI
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.